These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1558403)

  • 21. [A total subcutaneously implantable venous catheter system. 4 years' experience in cancer patients].
    Ludwig R; Ludwig CU; Laffer U; Stoll HR; Obrecht JP
    Schweiz Med Wochenschr; 1988 Mar; 118(9):305-8. PubMed ID: 3358106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Totally implanted venous and arterial access system to replace external catheters in cancer treatment.
    Niederhuber JE; Ensminger W; Gyves JW; Liepman M; Doan K; Cozzi E
    Surgery; 1982 Oct; 92(4):706-12. PubMed ID: 7123491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Subcutaneous chamber systems (ports) for long-term care in cancer patients].
    Hájek R; Sevcík P; Ondrásek J; Mayer J; Vásová I; Král Z; Tomíska M; Krahulcová E; Penka M; Kubesová H
    Vnitr Lek; 1995 Jan; 41(1):21-7. PubMed ID: 7716888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
    Pittiruti M; Hamilton H; Biffi R; MacFie J; Pertkiewicz M;
    Clin Nutr; 2009 Aug; 28(4):365-77. PubMed ID: 19464090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Totally implantable venous access device inserted during major abdominal operations for cancer. A new technique.
    Di Carlo I; Lombardo R; Russello D; Puleo S
    Hepatogastroenterology; 2000; 47(34):907-8. PubMed ID: 11020844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The complications of central venous access systems: a study of 218 patients.
    Torramadé JR; Cienfuegos JA; Hernández JL; Pardo F; Benito C; González J; Balén E; de Villa V
    Eur J Surg; 1993; 159(6-7):323-7. PubMed ID: 8104491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fully implantable catheter systems. Long-term results--complications].
    Wenke K; Markewitz A
    Fortschr Med; 1990 May; 108(14):276-9. PubMed ID: 2115492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of end-stage central venous access in children referred for possible small bowel transplantation.
    Rodrigues AF; van Mourik ID; Sharif K; Barron DJ; de Giovanni JV; Bennett J; Bromley P; Protheroe S; John P; de Ville de Goyet J; Beath SV
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):427-33. PubMed ID: 16641582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Totally implantable femoral vein catheters in cancer patients.
    Wolosker N; Yazbek G; Munia MA; Zerati AE; Langer M; Nishinari K
    Eur J Surg Oncol; 2004 Sep; 30(7):771-5. PubMed ID: 15296992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between peripherally implanted ports and externally sited catheters for long-term venous access.
    Pullyblank AM; Carey PD; Pearce SZ; Tanner AG; Guillou PJ; Monson JR
    Ann R Coll Surg Engl; 1994 Jan; 76(1):33-8. PubMed ID: 8117017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
    Koonings PP; Given FT
    J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.
    Schwarz RE; Groeger JS; Coit DG
    Cancer; 1997 Apr; 79(8):1635-40. PubMed ID: 9118051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insertion of Groshong central venous catheters utilizing fluoroscopic techniques.
    Burnett AF; Lossef SV; Barth KH; Grendys EC; Johnson JC; Barter JF; Barnes WA
    Gynecol Oncol; 1994 Jan; 52(1):69-73. PubMed ID: 8307504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of totally implantable venous system in cancer patients. Surgical technique and initial clinical experience].
    Ferranti F; Chichi GL; Mazzola L; Triveri P; Palmieri RM
    G Chir; 2002 May; 23(5):225-8. PubMed ID: 12228978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic therapy. Role of durable venous access.
    Rao VK; Charak BS; Giri NK; Banavali SD; Pai SK; Pai VR; Nadkarni KS; Kurkure PA; Saikia TK; Gopal R
    J Assoc Physicians India; 1990 Dec; 38(12):897-9. PubMed ID: 2096122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of catheter loops in central venous port systems.
    Behrendt FF; Wingen M; Katoh M; Guenther RW; Buecker A
    Invest Radiol; 2006 Nov; 41(11):777-80. PubMed ID: 17035867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgically implanted subcutaneous venous access devices in cancer patients.
    Repelaer van Driel OJ; Kuin CM; van de Velde CJ
    Neth J Surg; 1988 Jun; 40(4):97-9. PubMed ID: 3217033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fate of 100 prolonged venous access devices.
    Hayward SR; Ledgerwood AM; Lucas CE
    Am Surg; 1990 Sep; 56(9):515-9. PubMed ID: 2393188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannulation of inferior vena cava for long term central venous access.
    Curtas S; Bonaventura M; Meguid MM
    Surg Gynecol Obstet; 1989 Feb; 168(2):121-4. PubMed ID: 2911788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.